Technology area: Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Credo Diagnostics Biomedical Pte. Ltd. has 2 pending office actions in the Chemistry & Materials technology area. This activity involves 2 distinct examiners and distinct art units. Danielle B Henkel is the busiest examiner for the company, responsible for 1 of the pending office actions. Prosecution for Credo Diagnostics Biomedical Pte. Ltd. is currently divided between these distinct examiners.
Having 2 pending office actions spread across distinct examiners and art units indicates a diversified approach to patent prosecution. Danielle B Henkel handles 1 of the pending office actions, which is the same amount as the other examiner involved. This structure ensures that the company's progress in the Chemistry & Materials area is not tied to the decisions of just a single examiner. The involvement of multiple art units also suggests that the pending applications may cover different chemical or material classifications within the technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HENKEL, DANIELLE B | 1 | 56.4% | +23.4% |
| JARRETT, LORE RAMILLANO | 1 | 68.6% | +25.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18234388 | ANALYSIS CARTRIDGE and ANALYSIS METHOD | JARRETT, LORE RAMILLANO | 3d overdue |
| 18614724 | POLYMERASE CHAIN REACTION HEATING DEVICE AND POLYMERASE CHAIN REACTION TEMPERATURE CONTROL SYSTEM | HENKEL, DANIELLE B | — |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18614724 | POLYMERASE CHAIN REACTION HEATING DEVICE AND POLYMERASE CHAIN REACTION TEMPERATURE CONTROL SYSTEM | HENKEL, DANIELLE B | 1799 | §103 | Non-Final OA | — | Pending | Mar 24, 2024 |
| 18234388 | ANALYSIS CARTRIDGE and ANALYSIS METHOD | JARRETT, LORE RAMILLANO | 1797 | §112 | Final Rejection | 3d overdue | Pending | Aug 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCredo Diagnostics Biomedical Pte. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Danielle B Henkel has the most, with 1 of Credo Diagnostics Biomedical Pte. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
